These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 8415406)
41. C6- and C7-Substituted 3,4-dihydro-2(1H)-quinolinones as Inhibitors of Monoamine Oxidase. Meiring L; Petzer JP; Petzer A Drug Res (Stuttg); 2017 Mar; 67(3):170-178. PubMed ID: 27926950 [No Abstract] [Full Text] [Related]
42. Selective and potent monoamine oxidase type B inhibitors: 2-substituted 5-aryltetrazole derivatives. Lebreton L; Curet O; Gueddari S; Mazouz F; Bernard S; Burstein C; Milcent R J Med Chem; 1995 Nov; 38(24):4786-92. PubMed ID: 7490728 [TBL] [Abstract][Full Text] [Related]
43. Inhibition of monoamine oxidases by functionalized coumarin derivatives: biological activities, QSARs, and 3D-QSARs. Gnerre C; Catto M; Leonetti F; Weber P; Carrupt PA; Altomare C; Carotti A; Testa B J Med Chem; 2000 Dec; 43(25):4747-58. PubMed ID: 11123983 [TBL] [Abstract][Full Text] [Related]
45. Synthesis of 3-benzyl-2-substituted quinoxalines as novel monoamine oxidase A inhibitors. Hassan SY; Khattab SN; Bekhit AA; Amer A Bioorg Med Chem Lett; 2006 Mar; 16(6):1753-6. PubMed ID: 16356714 [TBL] [Abstract][Full Text] [Related]
46. Studies on monoamine oxidase. XVIII. Enzymic properties of placental monoamine oxidase. Egashira T Jpn J Pharmacol; 1976 Aug; 26(4):493-500. PubMed ID: 12389 [TBL] [Abstract][Full Text] [Related]
47. Development of selective and reversible pyrazoline based MAO-A inhibitors: Synthesis, biological evaluation and docking studies. Karuppasamy M; Mahapatra M; Yabanoglu S; Ucar G; Sinha BN; Basu A; Mishra N; Sharon A; Kulandaivelu U; Jayaprakash V Bioorg Med Chem; 2010 Mar; 18(5):1875-81. PubMed ID: 20149663 [TBL] [Abstract][Full Text] [Related]
48. Imidazole bearing chalcones as a new class of monoamine oxidase inhibitors. Sasidharan R; Baek SC; Sreedharannair Leelabaiamma M; Kim H; Mathew B Biomed Pharmacother; 2018 Oct; 106():8-13. PubMed ID: 29940538 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of rat brainstem monoamine oxidase activity by CGP 6085 A. Hurst JH; Kulakowski EC Life Sci; 1986 Oct; 39(16):1471-7. PubMed ID: 2430159 [TBL] [Abstract][Full Text] [Related]
51. Crystal structures, binding interactions, and ADME evaluation of brain penetrant N-substituted indazole-5-carboxamides as subnanomolar, selective monoamine oxidase B and dual MAO-A/B inhibitors. Tzvetkov NT; Stammler HG; Neumann B; Hristova S; Antonov L; Gastreich M Eur J Med Chem; 2017 Feb; 127():470-492. PubMed ID: 28107736 [TBL] [Abstract][Full Text] [Related]
52. A novel series of 6-substituted 3-(pyrrolidin-1-ylmethyl)chromen-2-ones as selective monoamine oxidase (MAO) A inhibitors. Mattsson C; Svensson P; Sonesson C Eur J Med Chem; 2014 Feb; 73():177-86. PubMed ID: 24393810 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of type A monoamine oxidase by 1-methyl-4-phenylpyridine. Takamidoh H; Naoi M; Nagatsu T Neurosci Lett; 1987 Jan; 73(3):293-7. PubMed ID: 3494215 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors. Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739 [TBL] [Abstract][Full Text] [Related]
55. In silico design of novel 2H-chromen-2-one derivatives as potent and selective MAO-B inhibitors. Pisani L; Farina R; Nicolotti O; Gadaleta D; Soto-Otero R; Catto M; Di Braccio M; Mendez-Alvarez E; Carotti A Eur J Med Chem; 2015 Jan; 89():98-105. PubMed ID: 25462230 [TBL] [Abstract][Full Text] [Related]
56. Monoamine oxidase inhibitory coumarins from the aerial parts of Dictamnus albus. Jeong SH; Han XH; Hong SS; Hwang JS; Hwang JH; Lee D; Lee MK; Ro JS; Hwang BY Arch Pharm Res; 2006 Dec; 29(12):1119-24. PubMed ID: 17225461 [TBL] [Abstract][Full Text] [Related]
57. 1,3,4-Oxadiazole-3(2H)-carboxamide derivatives as potential novel class of monoamine oxidase (MAO) inhibitors: synthesis, evaluation, and role of urea moiety. Ke S; Li Z; Qian X Bioorg Med Chem; 2008 Aug; 16(16):7565-72. PubMed ID: 18678501 [TBL] [Abstract][Full Text] [Related]
58. The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding. Medvedev AE; Shvedov VI; Chulkova TM; Fedotova OA; Saederup E; Squires RF J Neural Transm Suppl; 1998; 52():337-42. PubMed ID: 9564636 [TBL] [Abstract][Full Text] [Related]
59. Monoamine oxidase-inhibiting properties of SR 95191, a new pyridazine derivative, in the rat: evidence for selective and reversible inhibition of monoamine oxidase type A in vivo but not in vitro. Kan JP; Steinberg R; Leclercq J; Worms P; Biziere K J Neurochem; 1988 Apr; 50(4):1137-44. PubMed ID: 3346672 [TBL] [Abstract][Full Text] [Related]
60. Molecular determinants of MAO selectivity in a series of indolylmethylamine derivatives: biological activities, 3D-QSAR/CoMFA analysis, and computational simulation of ligand recognition. Morón JA; Campillo M; Perez V; Unzeta M; Pardo L J Med Chem; 2000 May; 43(9):1684-91. PubMed ID: 10794685 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]